ABN AMRO INVESTMENT SOLUTIONS
Position in NBIX — Neurocrine Biosciences Inc
CIK 2080520
PARIS CEDEX 008, I0
Position in NBIX
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$865,115
+$464,626 QoQ
Shares Held
5,133
+68.8% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#418
of 768 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ABN AMRO INVESTMENT SOLUTIONS holds $4,253,812 across 4 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (20.3% of the industry book) .
All Filings in NBIX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $865,115 | 5,133 | Shares | Other | 2026-07-23 | |
| 2026-03-31 | $400,489 | 3,040 | Shares | Other | 2026-05-12 | |
| 2025-12-31 | $383,791 | 2,706 | Shares | Defined | 2026-02-06 | |
| No filing history on record for this holder in this stock. | ||||||